US EditionNew Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment
Summary by Newswise
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
All
Left
Center
Right
Jersey Shore debuts N.J.’s first TAMP cancer therapy
Hackensack Meridian Jersey Shore University Medical Center has become the first hospital in New Jersey to offer a new, targeted treatment for pancreatic cancer using RenovoRx’s Trans-Arterial Micro-Perfusion (TAMP) therapy platform. Led by Dr. Gregory J. Tiesi, medical director of hepatobiliary surgery at the academic medical center, the oncology team has successfully treated its first patients with TAMP — a novel approach that delivers chemothe…
Newswise+2 Reposted by 2 other sources
New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment
Hackensack Meridian Jersey Shore University Medical Center experts have successfully treated their first patients using RenovoRx’s Novel Trans-Arterial Micro-Perfusion (TAMP™) therapy platform.
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
